Journal
GLOBAL PUBLIC HEALTH
Volume 12, Issue 3, Pages 281-299Publisher
ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
DOI: 10.1080/17441692.2016.1273368
Keywords
Japan Tobacco International; transnational tobacco industry; globalisation; global business strategy; tobacco control
Categories
Funding
- National Cancer Institute, US National Institutes of Health [R01-CA091021]
- Macquarie University [International Postgraduate Research Scholarship]
Ask authors/readers for more resources
Japan Tobacco International (JTI) is the international division of Japan Tobacco Incorporated, and the world's third largest transnational tobacco company. Founded in 1999, JTI's rapid growth has been the result of a global business strategy that potentially serves as a model for other Asian tobacco companies. This paper analyses Japan Tobacco Incorporated's global expansion since the 1980s in response to market opening, foreign competition, and declining share of a contracting domestic market. Key features of its global strategy include the on-going central role and investment by the Japanese government, and an expansion agenda based on mergers and acquisitions. The paper also discusses the challenges this global business strategy poses for global tobacco control and public health. This paper is part of the special issue 'The Emergence of Asian Tobacco Companies: Implications for Global Health Governance'.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available